The cytokine IL-15 controls the homeostasis and activation of CD8+ T cells and natural killer cells. A new study reveals the deubiquitinase Otub1 to be a negative regulator of IL-15 signaling, with important consequences for autoimmunity and anti-cancer immunity.
References
Kurioka, A., Klenerman, P. & Willberg, C.B. Immunology https://doi.org/10.1111/imm.12925 (2018).
Lin, J. X. & Leonard, W. J. Cold Spring Harb. Perspect. Biol. 10, a028449 (2018).
Zhou, X. et al. Nat. Immunol. https://doi.org/10.1038/s41590-019-0405-2 (2019).
Castillo, E. F. & Schluns, K. S. Cytokine 59, 479–490 (2012).
Deshpande, P. et al. J. Immunol. 190, 1416–1423 (2013).
Hao, M. et al. Biochem. Pharmacol. 147, 128–140 (2018).
Yuan, L. et al. Am. J. Cancer Res. 7, 159–172 (2017).
Herhaus, L. et al. Sci. Signal. 8, ra35 (2015).
Li, Y. et al. J. Biol. Chem. 289, 5097–5108 (2014).
Scholz, C. C. et al. PLoS Biol. 14, e1002347 (2016).
Saldana, M., VanderVorst, K., Berg, A. L., Lee, H. & Carraway, K. L. Endocr. Relat. Cancer 26, R1–R14 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Moynagh, P.N. IL-15 in autoimmunity and cancer: O-tu-b or not O-tu-b?. Nat Immunol 20, 780–782 (2019). https://doi.org/10.1038/s41590-019-0424-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-019-0424-z
- Springer Nature America, Inc.
This article is cited by
-
Resilient T-cell responses in patients with advanced cancers
International Journal of Hematology (2023)